Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer (Q33387924)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer |
scientific article |
Statements
1 reference
Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer (English)
1 reference
Giorgio Scagliotti
1 reference
Alberto Chiappori
1 reference
Gerold Bepler
1 reference
Fabrice Barlesi
1 reference
Martin Reck
1 reference
Fernando Barata
1 reference
Keunchil Park
1 reference
Asavari Wagle
1 reference
Astra M Liepa
1 reference
Yan Daniel Zhao
1 reference
Nadia Chouaki
1 reference
Neill Iscoe
1 reference
Joachim von Pawel
1 reference
1 March 2010
1 reference
1 reference
369-375
1 reference
Identifiers
1 reference
1 reference